Literature DB >> 8926088

Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells.

J A Garner1, T L Cover.   

Abstract

Many Helicobacter pylori strains produce a cytotoxin (VacA) that induces vacuolation in epithelial cells. In this study, binding and internalization of the cytotoxin by HeLa or AGS (human gastric adenocarcinoma) cells were characterized by indirect fluorescence microscopy. Cells incubated with the cytotoxin at 4 degrees C displayed a uniform fluorescent plasma membrane signal. Preincubation of the cytotoxin with either rabbit antiserum to approximately 90-kDa H. pylori VacA or sera from H. pylori-infected persons inhibited its binding to cells and blocked its capacity to induce cytoplasmic vacuolation. Recombinant VacA fragments (approximately 34 and approximately 58 kDa), corresponding to two proteolytic cleavage products of approximately 90-kDa VacA, each bound to the plasma membrane of HeLa cells. Antiserum reactive with the approximately 58-kDa VacA fragment inhibited the binding of native H. pylori cytotoxin to cells and inhibited cytotoxin activity, whereas antiserum to the approximately 34-kDa fragment had no effect. When incubated with cells at 37 degrees C for > or = 3 h, the H. pylori cytotoxin localized intracellularly in a perinuclear location but did not localize within cytotoxin-induced vacuoles. When cells with previously bound cytotoxin were incubated with anticytotoxin serum at 4 degrees C and then shifted to 37 degrees C, vacuolation was completely inhibited. Bound cytotoxin became inaccessible to the neutralizing effects of antiserum after 60 to 120 min of incubation with cells at 37 degrees C. These data suggest a model in which (i) VacA binds to cells primarily via amino acid sequences in its 58-kDa fragment, (ii) VacA internalization occurs slowly in a temperature-dependent process, and (iii) VacA interacts with an intracellular target.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926088      PMCID: PMC174356          DOI: 10.1128/iai.64.10.4197-4203.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Helicobacter pylori and peptic ulcer disease.

Authors:  W L Peterson
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

Review 2.  Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention.

Authors:  T L Cover; M J Blaser
Journal:  Adv Intern Med       Date:  1996

3.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.

Authors:  N Figura; P Guglielmetti; A Rossolini; A Barberi; G Cusi; R A Musmanno; M Russi; S Quaranta
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Purification and characterization of the vacuolating toxin from Helicobacter pylori.

Authors:  T L Cover; M J Blaser
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

5.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Authors:  T G Obrig; P J Del Vecchio; J E Brown; T P Moran; B M Rowland; T K Judge; S W Rothman
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin.

Authors:  T L Cover; W Puryear; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

7.  Studies on the binding of staphylococcal 125I-labeled alpha-toxin to rabbit erythrocytes.

Authors:  P Cassidy; S Harshman
Journal:  Biochemistry       Date:  1976-06-01       Impact factor: 3.162

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  61 in total

1.  Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation.

Authors:  D Ye; S R Blanke
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion.

Authors:  X Ji; T Fernandez; D Burroni; C Pagliaccia; J C Atherton; J M Reyrat; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Dynamin is involved in human epithelial cell vacuolation caused by the Helicobacter pylori-produced cytotoxin VacA.

Authors:  J Suzuki; H Ohnsihi; H Shibata; A Wada; T Hirayama; T Iiri; N Ueda; C Kanamaru; T Tsuchida; H Mashima; H Yasuda; T Fujita
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Role of vacA and cagA in Helicobacter pylori inhibition of mucin synthesis in gastric mucous cells.

Authors:  W Beil; M L Enss; S Müller; B Obst; K F Sewing; S Wagner
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

6.  Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.

Authors:  David C Willhite; Dan Ye; Steven R Blanke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Use of a novel enzyme immunoassay based on detection of circulating antigen in serum for diagnosis of Helicobacter pylori infection.

Authors:  Abdelfattah M Attallah; Hisham Ismail; Gellan G Ibrahim; Mohamed Abdel-Raouf; Ahmed M El-Waseef; Mohamed Abdel-Wahab
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH.

Authors:  D M Czajkowsky; H Iwamoto; T L Cover; Z Shao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

9.  Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.

Authors:  D Kuck; B Kolmerer; C Iking-Konert; P H Krammer; W Stremmel; J Rudi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

10.  Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.

Authors:  E Papini; B Satin; N Norais; M de Bernard; J L Telford; R Rappuoli; C Montecucco
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.